1. 11PA SNP germinal signature for predicting checkpoint inhibitor treatment outcome. (17th December 2018) Authors: Milano, G; Refae, S; Gal, J; Ebran, N; Otto, J; Shell, S; Everts, R; Chamorey, E; Saada-Bouzid, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 10 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1664OA randomized non-comparative phase II study of anti–PD-L1 ATEZOLIZUMAB or chemotherapy as second-line therapy in patients with small cell lung cancer: Results from the IFCT-1603 trial. (23rd October 2018) Authors: Pujol, J-L; Greillier, L; Audigier Valette, C; Moro-Sibilot, D; Uwer, L; Hureaux, J; Thiberville, L; Carmier, D; Madelaine, J; Otto, J; Gounant, V; Merle, P; Mourlanette, P; Molinier, O; Renault, P A; Mazieres, J; Antoine, M; Langlais, A; Morin, F; Souquet, P-J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial. (4th October 2019) Authors: Moro-Sibilot, D; Cozic, N; Pérol, M; Mazières, J; Otto, J; Souquet, P J; Bahleda, R; Wislez, M; Zalcman, G; Guibert, S D; Barlési, F; Mennecier, B; Monnet, I; Sabatier, R; Bota, S; Dubos, C; Verriele, V; Haddad, V; Ferretti, G; Cortot, A Journal: Annals of oncology Issue: Volume 30:Number 12(2019) Page Start: 1985 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Facilities and equipment in district general hospitals in the Netherlands: Are we prepared for the critically ill paediatric patients?. Issue 1 (20th January 2004) Authors: Van der Lely, N; van Marion, P J C; Otto, J; Hazelzet, J A; Büller, H A Journal: Emergency medicine journal Issue: Volume 21:Issue 1(2004) Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. LBA56Maintenance chemotherapy versus follow-up after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): IFCT-1201 MODEL randomised phase III trial. (23rd October 2018) Authors: Quoix, E; Audigier Valette, C; Lavolé, A; Molinier, O; Westeel, V; Barlesi, F; Le Treut, J; Pichon, E; Dauba, J; Otto, J; Dumont, P; Moreau, L; Madelaine, J; Margery, J; Debieuvre, D; Renault, P A; Langlais, A; Morin, F; Moro-Sibilot, D; Souquet, P-J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗